Innovation at the service of digital health

We leverage artificial intelligence to boost stroke prevention

Experts in supercomputing and artificial intelligence: committed to health

At Innostroke, we believe in prevention as a key measure to combat stroke. This project was born with this vision from the Barcelona Supercomputing Center (BSC) through the Computer Sciences – Workflows and Distributed Computing and Life Sciences – Machine Learning for Biomedical Research groups.

We specialize in Digital Health and Personalized Medicine (eHealth), leveraging emerging technologies and digital tools to enhance medical care, making it more efficient, precise, and tailored to individual needs. Our work focuses on three key pillars within this field:

Stroke prevention and ongoing monitoring

We integrate advanced technologies, such as artificial intelligence (AI) and high-performance computing (HPC), to enhance stroke prevention and continuous monitoring, addressing one of the leading causes of death and disability worldwide.

Application of AI in personalized medicine

This technology enables personalized stroke prevention by integrating data on lifestyle, cardiovascular factors, and genetic and molecular biomarkers. This represents a key advance in personalized and predictive medicine.

Desarrollo de plataformas digitales de salud

Our project focuses on developing digital health platforms tailored for hospital environments. These platforms integrate AI-driven solutions with genetic and molecular data, enhancing the prediction and prevention of cerebrovascular diseases.

Our goals

The Innostroke project seeks to establish a commercially viable and scalable business model. To achieve this, it focuses on three main objectives:

Validation and operational deployment of the AI ​​platform

We will conduct a proof of concept in collaboration with the Hospital de la Santa Creu i Sant Pau and Hospital Universitari de Bellvitgel. This process will enable us to refine and optimize the SaaS platform (Software as a Service) based on the results, paving the way for its strategic market introduction.

Regulatory and ethical compliance

We are committed to complying with current regulatory and ethical standards regarding the EU Medical Devices Regulation and AI Act. These are key to healthcare innovations, thus ensuring continuous improvement of project outcomes. In addition, we prioritize cybersecurity in line with the requirements set by the ISO standard.

Roadmap for the creation of a spin-off

In order to create the OneCareAI spin-off from BSC, we are developing the legal documentation and a strategic business plan that will allow us to effectively transfer the technology and successfully position it in the market.

Partners

We will validate the Innostroke technology through a proof of concept (PoC) in collaboration with partner hospitals, evaluating its economic viability and effectiveness in a relevant environment through two case studies as a basis.

Barcelona Supercompuring Center: Coordination and development of the Innostroke software prototype.

Hospital de la Santa Creu i Sant Pau (Barcelona): One of the leading clinical research centres in Spain, collaborating in the validation and testing of the platform in a hospital environment.

Hospital Universitario de Bellvitge (Barcelona): One of the hospitals collaborating in pilot tests that validate the effectiveness and scalability of the Innostroke platform.

Hospital Niguarda (Milán): One of the hospitals collaborating in pilot tests that validate the effectiveness and scalability of the Innostroke platform.

Logos

Download negative version

Download color version

Download positive version

Download black version

Generic flyer